Preventing vision loss from glaucoma: putting data from clinical trials into practice.
Glaucoma is a group of ocular diseases that cause progressive changes in the optic nerve head and/or visual field loss. An elevated intraocular pressure (IOP) is often, but not always, present. Data from five large-scale clinical trials suggest that the greater the IOP reduction, the greater the protection against visual field loss. Corneal thickness is now recognized as an important predictor of glaucoma progression. The thinner the cornea is, the greater the risk of progression.
Schoenleber
Dan B
DB
University of Missouri-Columbia School of Medicine, USA.
D001766:Blindness / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003315:Cornea / Q000502:physiology; D018450:Disease Progression; D005901:Glaucoma / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009883:Ophthalmic Solutions; D009900:Optic Nerve / Q000187:drug effects / Q000473:pathology; D012307:Risk Factors; D014794:Visual Fields / Q000187:drug effects
D009883:Ophthalmic Solutions